Skip to main content
. 2022 May 3;13:893929. doi: 10.3389/fimmu.2022.893929

Table 3.

Complications and treatments of septic survivors and non-survivors.

Variables Total (n=25) Sepsis (n=25)
Survivors (n=14) Non-survivors (n=11) P value
Complications, n (%)
Acute kidney injury 6 (24.0) 2 (14.29) 4 (36.36) 0.199
Liver dysfunction 7 (28.0) 4 (28.57) 3 (27.27) 1
Acute heart failure 3 (12.0) 1 (7.14) 2 (18.18) 0.565
Gastrointestinal bleeding 7 (28.0) 3 (21.43) 4 (36.36) 0.656
Pleural effusion 10 (40.0) 7 (50) 3 (27.27) 0.414
Treatment and progress, n (%)
IMV 14 (56.0) 7 (50) 7 (63.64) 0.589
ECMO 1 (4.0) 1 (7.14) 0 0.366
CRRT 4 (16.0) 1 (7.14) 3 (27.27) 0.288
Vasopressor 16 (64.0) 8 (57.14) 8 (72.73) 0.677
Sedative 18 (72.0) 11 (78.57) 7 (63.64) 0.656
Parenteral nutrition 12 (48.0) 5 (35.71) 7 (63.64) 0.238
ICU days 12.0 (8.0~17.0) 11.0 (8.0~19.3) 12.0 (7.0~17.0) 0.68
Ventilator-free days 24.0 (17.0~26.0) 24.5 (20.3~26.0) 23.0 (15.0~26.0) 0.678

IMV, invasive mechanical ventilation; ECMO, extracorporeal membrane oxygenation; CRRT, continuous renal replacement therapy; ICU, intensive care unit.